Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 109151-109200 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03364530
Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma
PHASE2Recruiting
40 participants
Started: Jun 11, 2018 · Completed: Jun 10, 2026
2 conditions2 sponsors7 locations
NCT03459456
Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)
N/AActive, not recruiting
27 participants
Started: Jun 11, 2018 · Completed: Jul 31, 2026
2 conditions3 sponsors3 locations
NCT03079999
Study of Aspirin in Patients With Vestibular Schwannoma
PHASE2Recruiting
300 participants
Started: Jun 11, 2018 · Completed: Feb 28, 2029
3 conditions2 sponsors6 locations
NCT03516942
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
N/AActive, not recruiting
565 participants
Started: Jun 11, 2018 · Completed: Sep 1, 2028
18 conditions2 sponsors716 locations
NCT03540745
Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders
NAActive, not recruiting
14 participants
Started: Jun 11, 2018 · Completed: Nov 30, 2019
4 conditions2 sponsors1 location
NCT03632356
A Multi-Site RCT of a Stepped-Care Intervention for Emergency Department Patients With Panic Attacks and Panic Disorder
NAActive, not recruiting
79 participants
Started: Jun 11, 2018 · Completed: Nov 30, 2024
1 condition4 sponsors1 location
NCT03308305
Cracking Coma: Towards EEG and MRI Based Precision Medicine After Cardiac Arrest
N/AActive, not recruiting
100 participants
Started: Jun 11, 2018 · Completed: Dec 31, 2025
1 condition3 sponsors3 locations
NCT03539692
Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site
N/ARecruiting
1,000 participants
Started: Jun 10, 2018 · Completed: Dec 31, 2028
1 condition3 sponsors1 location
NCT03755791
Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Subjects With Advanced HCC Who Have Not Received Previous Systemic Anticancer Therapy
PHASE3Active, not recruiting
837 participants
Started: Jun 10, 2018 · Completed: Dec 1, 2024
1 condition1 sponsor245 locations
NCT03392181
PET/MRI for the Staging of Newly Diagnosed Prostate Cancer
EARLY_PHASE1Active, not recruiting
48 participants
Started: Jun 8, 2018 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT03556228
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
PHASE1Recruiting
82 participants
Started: Jun 8, 2018 · Completed: Jun 30, 2027
18 conditions1 sponsor15 locations
NCT03554902
Endoscopic Gastric Tubulization
N/ARecruiting
300 participants
Started: Jun 8, 2018 · Completed: Jun 30, 2028
1 condition1 sponsor1 location
NCT03507049
Sacroiliac Joint Fusion Versus Sham Operation for Treatment of Sacroiliac Joint Pain
NAActive, not recruiting
63 participants
Started: Jun 8, 2018 · Completed: May 25, 2030
1 condition2 sponsors2 locations
NCT03461159
Operant Conditioning for Neuromodulation
NARecruiting
60 participants
Started: Jun 8, 2018 · Completed: Jun 30, 2024
2 conditions3 sponsors1 location
NCT04457193
Outcomes After Transoral Incisionless Fundoplication (TIF) Following Successful Endoscopic Ablation for Barrett's Esophagus
N/AEnrolling by invitation
50 participants
Started: Jun 7, 2018 · Completed: Jun 7, 2027
2 conditions1 sponsor1 location
NCT03572374
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
NARecruiting
546 participants
Started: Jun 7, 2018 · Completed: Jun 30, 2026
1 condition1 sponsor9 locations
NCT03441971
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
NAActive, not recruiting
15 participants
Started: Jun 7, 2018 · Completed: Mar 31, 2030
4 conditions1 sponsor3 locations
NCT03562572
FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel Disease
NAActive, not recruiting
476 participants
Started: Jun 7, 2018 · Completed: Jul 31, 2027
5 conditions9 sponsors9 locations
NCT03342625
High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study
NARecruiting
15 participants
Started: Jun 7, 2018 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT06336941
"Ultra-High Frequency intraOral UltraSonography of the TONgue (HOUSTON)"
NARecruiting
400 participants
Started: Jun 7, 2018 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT03294083
A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma
PHASE1/PHASE2Active, not recruiting
89 participants
Started: Jun 7, 2018 · Completed: Nov 30, 2023
1 condition2 sponsors18 locations
NCT03377543
Sleep and Inflammatory Resolution Pathway
EARLY_PHASE1Active, not recruiting
66 participants
Started: Jun 6, 2018 · Completed: Dec 30, 2025
4 conditions1 sponsor1 location
NCT03448042
A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
PHASE1Active, not recruiting
123 participants
Started: Jun 6, 2018 · Completed: Dec 30, 2026
1 condition1 sponsor27 locations
NCT04236492
Study Protocol to Evaluate Clinical and Imaging Results of Knee Fresh Osteochondral Allografts
N/ARecruiting
40 participants
Started: Jun 6, 2018 · Completed: Nov 10, 2026
1 condition2 sponsors1 location
NCT03498378
Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PHASE1Active, not recruiting
24 participants
Started: Jun 6, 2018 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT03563729
Melanoma Metastasized to the Brain and Steroids
PHASE2Recruiting
80 participants
Started: Jun 6, 2018 · Completed: Jun 6, 2028
1 condition1 sponsor3 locations
NCT03387553
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
EARLY_PHASE1Active, not recruiting
31 participants
Started: Jun 6, 2018 · Completed: Aug 29, 2026
8 conditions2 sponsors1 location
NCT03552926
Constitution of a Clinico-radiological Database and a Biobank for Patients With Lacunar Infarcts
N/ARecruiting
500 participants
Started: Jun 6, 2018 · Completed: Aug 30, 2027
1 condition1 sponsor1 location
NCT03538912
Early Discontinuation of Empirical Antifungal Therapy and Biomarkers
NARecruiting
194 participants
Started: Jun 6, 2018 · Completed: Jun 30, 2025
1 condition1 sponsor10 locations
NCT02965716
Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
PHASE2Active, not recruiting
43 participants
Started: Jun 5, 2018 · Completed: Nov 18, 2025
8 conditions1 sponsor20 locations
NCT04240652
The Diabetic Retinopathy Screening, Prevention and Control Program
N/ARecruiting
500,000 participants
Started: Jun 5, 2018 · Completed: Jun 5, 2040
1 condition1 sponsor2 locations
NCT04552509
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
NARecruiting
167 participants
Started: Jun 5, 2018 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT03514069
Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
PHASE1Active, not recruiting
60 participants
Started: Jun 5, 2018 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03210714
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
PHASE2Active, not recruiting
20 participants
Started: Jun 5, 2018 · Completed: Dec 31, 2025
32 conditions1 sponsor116 locations
NCT03465982
Timing to Minimally Invasive Surgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer
NARecruiting
340 participants
Started: Jun 5, 2018 · Completed: Jun 5, 2029
1 condition1 sponsor14 locations
NCT02942927
Team Approach to Polypharmacy Evaluation and Reduction
NARecruiting
360 participants
Started: Jun 4, 2018 · Completed: Dec 31, 2024
3 conditions4 sponsors1 location
NCT03835663
The Bacterial Composition of the Stomach in Reflux Disease
N/AActive, not recruiting
100 participants
Started: Jun 4, 2018 · Completed: Dec 31, 2024
8 conditions1 sponsor1 location
NCT03584165
Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa
PHASE3Enrolling by invitation
330 participants
Started: Jun 4, 2018 · Completed: Jun 4, 2026
2 conditions1 sponsor25 locations
NCT03539614
Predicting Responses to PTSD Treatment With Iris and Cardiovascular Tests
PHASE3Active, not recruiting
87 participants
Started: Jun 4, 2018 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT03600649
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
PHASE1Active, not recruiting
50 participants
Started: Jun 4, 2018 · Completed: Dec 31, 2025
11 conditions2 sponsors16 locations
NCT03541083
Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults.
PHASE2Active, not recruiting
71 participants
Started: Jun 4, 2018 · Completed: Dec 15, 2026
1 condition1 sponsor18 locations
NCT03645824
Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF)
PHASE2Active, not recruiting
61 participants
Started: Jun 4, 2018 · Completed: Feb 28, 2027
1 condition3 sponsors12 locations
NCT03570450
Regenerative Stem Cell Therapy for Stroke in Europe 1-RESSTORE1
PHASE1Recruiting
95 participants
Started: Jun 2, 2018 · Completed: Jul 1, 2027
1 condition30 sponsors1 location
NCT04879069
Polish Multicenter PERTs PE Outcomes Registry
N/ARecruiting
10,000 participants
Started: Jun 1, 2018 · Completed: Dec 31, 2030
1 condition2 sponsors1 location
NCT03363932
French Observatory of Congenital Ventricular Septal Defect With Pulmonary Overload
N/AActive, not recruiting
218 participants
Started: Jun 1, 2018 · Completed: Jun 30, 2030
1 condition1 sponsor4 locations
NCT03901521
Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository
N/AEnrolling by invitation
100 participants
Started: Jun 1, 2018 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT03323554
Safety and Efficacy Study of USTRAP™ in Male Urinary Incontinence
NAActive, not recruiting
20 participants
Started: Jun 1, 2018 · Completed: Dec 1, 2026
1 condition2 sponsors1 location
NCT06268470
Antiplatelet Therapy in Chronic Urticaria
PHASE2Active, not recruiting
12 participants
Started: Jun 1, 2018 · Completed: May 1, 2024
1 condition1 sponsor1 location
NCT03060434
Pentoxifylline and Lumbar Radiculopathy
PHASE4Active, not recruiting
67 participants
Started: Jun 1, 2018 · Completed: Dec 1, 2026
3 conditions1 sponsor1 location
NCT05965453
Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome
N/ARecruiting
205 participants
Started: Jun 1, 2018 · Completed: Jun 1, 2032
1 condition10 sponsors1 location